Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation.

Fontan Fontan-associated liver disease (FALD) congestive hepatopathy elastography hepatic vein waveform liver fibrosis

Journal

Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 29 05 2018
revised: 27 08 2018
accepted: 30 08 2018
pubmed: 6 9 2018
medline: 6 9 2018
entrez: 6 9 2018
Statut: ppublish

Résumé

Liver fibrosis caused by congestive hepatopathy has emerged as an important complication after Fontan procedure. We evaluated the utility of the hepatic vein (HV) waveform using Doppler ultrasound for identification of liver fibrosis in Fontan patients. We investigated the HV waveforms in 41 Fontan patients and assessed correlations with clinical parameters, liver fibrosis markers, and hemodynamic data. Based on our preliminary analysis of 64 adult patients with chronic liver disease who underwent liver biopsy, we classified HV waveforms into five types with reference to the degree of flattening (from type 1, normal triphasic waveform; to type 5, a monophasic waveform indicating cirrhosis), and confirmed a significant correlation between waveform pattern and fibrosis stage. Notably, we detected HV waveforms in all of the Fontan patients and classified them into five types. The HV waveform pattern positively correlated with γ-glutamyl transferase and hyaluronic acid levels, and negatively correlated with albumin level and platelet count, but did not correlate with central venous pressure or brain natriuretic peptide level, suggesting that HV waveform could reflect pathophysiological changes in the liver without being affected by hepatic congestion. The highest area under the receiver operating characteristic curve of the HV waveform for detecting advanced liver fibrosis, as defined by ultrasonic findings and clinical features, was 0.829 (81.8% sensitivity, 73.3% specificity), which was higher than that of other non-invasive fibrosis markers. Hepatic vein waveforms change in accordance with liver fibrosis progression in Fontan patients, and can be a useful indicator of liver fibrosis after the Fontan procedure.

Identifiants

pubmed: 30182424
doi: 10.1111/hepr.13248
doi:

Types de publication

Journal Article

Langues

eng

Pagination

304-313

Subventions

Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP17fk0210304
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18fk0210040

Informations de copyright

© 2018 The Japan Society of Hepatology.

Auteurs

Takuma Nakatsuka (T)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yoko Soroida (Y)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Hayato Nakagawa (H)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Takahiro Shindo (T)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Masaya Sato (M)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Katsura Soma (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Ryo Nakagomi (R)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Tamaki Kobayashi (T)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Momoe Endo (M)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Hiromi Hikita (H)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Mamiko Sato (M)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Hiroaki Gotoh (H)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Tomomi Iwai (T)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Mariko Yasui (M)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Aya Shinozaki-Ushiku (A)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kazuhiro Shiraga (K)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hiroko Asakai (H)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yoichiro Hirata (Y)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Masashi Fukayama (M)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hitoshi Ikeda (H)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Yutaka Yatomi (Y)

Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

Ryosuke Tateishi (R)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Ryo Inuzuka (R)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kazuhiko Koike (K)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Classifications MeSH